Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Fürst

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Oncology Letters|September 21, 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer onlyLinda Hertlein, Johanna Rath, Christine Zeder-Göss, et al.
Archives of Gynecology and Obstetrics|April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screeningLinda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Clinical Chemistry and Laboratory Medicine|September 20, 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian massesMiriam Lenhard, Petra Stieber, Linda Hertlein, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
Cancers|April 3, 2021
EP4 as a Negative Prognostic Factor in Patients with Vulvar CancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Histochemistry and Cell Biology|June 24, 2020
Cytoplasmic VDR expression as an independent risk factor for ovarian cancerBastian Czogalla, Eileen Deuster, Yue Liao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2020
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 studyRudiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Gynecologic Oncology|July 21, 2019
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 studyLinn Woelber, Christine Eulenburg, Jens Kosse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Oncology Letters|September 21, 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer onlyLinda Hertlein, Johanna Rath, Christine Zeder-Göss, et al.
Archives of Gynecology and Obstetrics|April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screeningLinda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Clinical Chemistry and Laboratory Medicine|September 20, 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian massesMiriam Lenhard, Petra Stieber, Linda Hertlein, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
Cancers|April 3, 2021
EP4 as a Negative Prognostic Factor in Patients with Vulvar CancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Histochemistry and Cell Biology|June 24, 2020
Cytoplasmic VDR expression as an independent risk factor for ovarian cancerBastian Czogalla, Eileen Deuster, Yue Liao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2020
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 studyRudiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Gynecologic Oncology|July 21, 2019
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 studyLinn Woelber, Christine Eulenburg, Jens Kosse, et al.
Pageof 2